[HTML][HTML] Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA. Preliminary results of a …
EM Idelsis, PE Jesus, DR Yaquelin, VB Dania… - 2020 - pesquisa.bvsalud.org
Abstract Objectives: IFN-alpha2b and IFN-gamma combination has demonstrated favorable
pharmacodynamics for genes underlying antiviral activity which might be involved in the …
pharmacodynamics for genes underlying antiviral activity which might be involved in the …
[HTML][HTML] Péptido inmunomodulador CIGB-258 para el tratamiento de pacientes graves y críticos con la COVID-19
…, D Oliva Pérez, LR Cruz, I Esquivel Moynelo… - Revista Cubana de …, 2020 - scielo.sld.cu
Objetivos: Establecer la frecuencia de dosis y el tiempo de tratamiento con el péptido CIGB-258,
para pacientes críticos con COVID-19. Además, definir los criterios de uso y el …
para pacientes críticos con COVID-19. Además, definir los criterios de uso y el …
Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA. Preliminary results of a …
II Esquivel-Moynelo, J Pérez-Escribano… - medRxiv, 2020 - medrxiv.org
Objectives An IFN-α2b and IFN-γ combination has demonstrated favorable pharmacodynamics
for genes underlying antiviral activity which might be involved in the defense of a host …
for genes underlying antiviral activity which might be involved in the defense of a host …
CIGB-258, inhibitor peptide of hyperinflammation in COVID-19 patients
…, R Santana Sánchez, I Esquivel Moynelo - Anales de la …, 2022 - inis.iaea.org
[en] Introduction. CIGB-258 is a peptide, whose mechanism of action has been associated
with the inhibition of inflammation. This paper aims to demonstrate that CIGB-258 reduces …
with the inhibition of inflammation. This paper aims to demonstrate that CIGB-258 reduces …
Phase II randomized controlled trial to evaluate the efficacy and safety of HeberFERON versus Heberon alpha R in symptomatic or asymptomatic patients infected with …
…, CM Suarez, I Campa-Legrá, I Esquivel-Moynelo… - 2020 - researchsquare.com
Background: As the outbreak of COVID-19 has accelerated, an urgent need for finding strategies
to combat the virus is growing. Results from in vitro studies suggest that a combination …
to combat the virus is growing. Results from in vitro studies suggest that a combination …
[HTML][HTML] CIGB-258, péptido inhibidor de la hiperinflamación en pacientes con COVID-19
…, L Rosario Cruz, I Esquivel Moynelo - Anales de la …, 2022 - scielo.sld.cu
Introducción: El CIGB-258 es un péptido, cuyo mecanismo de acción se ha asociado con la
inhibición de la inflamación. El presente trabajo tiene como objetivo demostrar que el CIGB-…
inhibición de la inflamación. El presente trabajo tiene como objetivo demostrar que el CIGB-…
[HTML][HTML] Early treatment with a peptide derived from the human heat-shock 60 protein avoids progression to severe stages of COVID-19
JEB Hernández, ADR Martín, LDR Cruz… - … of Biotechnology and …, 2021 - fortuneonline.org
Hyperinflammatory response induced by SARS-CoV-2 characterizes COVID-19 patients
progressing to severe conditions. CIGB-258 is an immunoregulatory peptide with anti-…
progressing to severe conditions. CIGB-258 is an immunoregulatory peptide with anti-…
[HTML][HTML] Evaluation of the Effect and Safety of HeberFERON vs Heberon Alpha in Patients Infected with Corona Virus SARS-CoV-2 (Study ESPERANZA/HOPE): Study …
B Iraldo, F Hernandez-Bernal, H Nodarse-Cuni… - 2020 - europepmc.org
Background: As the outbreak of COVID-19 has accelerated, an urgent need for finding strategies
to combat the virus is growing. Results from in vitro studies suggest that a combination …
to combat the virus is growing. Results from in vitro studies suggest that a combination …
The role of type I interferon in the treatment of COVID‐19
F Sodeifian, M Nikfarjam, N Kian… - Journal of medical …, 2022 - Wiley Online Library
Although significant research has been done to find effective drugs against coronavirus
disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐…
disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐…
[PDF][PDF] Heberferon May Contain The SARS-Cov-2 Infection
IB Rivero, Y Duncan-Roberts… - Biomedical Journal of …, 2020 - researchgate.net
Introduction Human coronavirus is an important agent causing mild-tosevere respiratory tract
infections in humans. It is clear that viral dissemination is determinant in the establishment …
infections in humans. It is clear that viral dissemination is determinant in the establishment …